Related Experiment Video
Updated: Jun 19, 2026

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental
Anna Czech1, Paweł Piatkiewicz, Jan Tatoń
1Chair and Department of Internal Medicine, and Diabetology, Warsaw Medical University (Brodnowski Hospital), Warsaw, Poland.
Introduction:
The normalization of cellular glucose assimilation is the basic aim of metabolic therapy in type 2 diabetes mellitus (T2DM). It requires parallel changes in the process of cellular glucose transport (CGT). Therefore the level of CGT could be regarded as a therapeutic target for oral hypoglycemic drugs in T2DM. To explore this hypothesis, CGT levels before and after sulfonylurea therapy were investigated. Peripheral blood lymphocytes were used as a cell model for testing CGT.
Materials And Methods:
CGT was assessed by experimental in vitro tests allowing timed comparative observation of the transport process during the incubation of lymphocytes with 2-[(3)H(G)] glucose under basal conditions and after the addition of sulfonylurea or sulfonylurea plus insulin. The incubation tests were performed at baseline in 28 persons with newly diagnosed, therapy-naive T2DM and in 20 control subjects. In the diabetic patients the tests for CGT were repeated after 3 months of sulfonylurea therapy. The level of glucotransporter 4 (GLUT4) expression was also assessed by flow cytometry before and after the therapy.
Results:
Before treatment, CGT was significantly lower in the subjects with T2DM. The cells responded to the addition of sulfonylurea by a moderate increase in CGT. This response was augmented by the addition of insulin to sulfonylurea in the culture medium.
Conclusions:
The three-month therapy with sulfonylurea resulted in a significant increase in CGT in all types of culture tests. This sulfonylurea-related improvement in CGT was associated with a near normalization of GLUT4 expression in the cells.
Insights
Sulfonylurea therapy significantly improved cellular glucose transport (CGT) in type 2 diabetes mellitus (T2DM) patients. This enhancement normalized glucose transporter 4 (GLUT4) expression, suggesting CGT as a therapeutic target.
Area of Science:
- Metabolic research
- Diabetes mellitus treatment
- Cellular physiology
Background:
- Cellular glucose assimilation is key for type 2 diabetes mellitus (T2DM) metabolic therapy.
- Cellular glucose transport (CGT) levels are potential therapeutic targets for oral hypoglycemic drugs.
- Investigating CGT levels before and after sulfonylurea therapy in T2DM.
Purpose of the Study:
- To determine if CGT levels can be a therapeutic target in T2DM.
- To assess the impact of sulfonylurea therapy on CGT.
- To evaluate changes in GLUT4 expression following sulfonylurea treatment.
Main Methods:
- Assessed CGT using in vitro tests with 2-[(3)H(G)] glucose on peripheral blood lymphocytes.
- Incubation tests performed under basal conditions and with sulfonylurea +/- insulin.
- Assessed GLUT4 expression via flow cytometry before and after 3 months of sulfonylurea therapy in T2DM patients.
Main Results:
- Baseline CGT was significantly lower in T2DM patients compared to controls.
- Sulfonylurea moderately increased CGT in T2DM lymphocytes.
- Insulin augmented the sulfonylurea-induced increase in CGT.
Conclusions:
- Three-month sulfonylurea therapy significantly increased CGT in T2DM patients.
- The observed improvement in CGT correlated with near-normal GLUT4 expression.
- These findings support CGT as a viable therapeutic target in T2DM management.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Secondary Active Transport
Secondary Active Transport
Glucose Absorption Into the Small Intestine
Transcellular Transport of Solutes
Membrane Proteins

